ELE Biotech aims to transform the way dementias are identified and managed worldwide to significantly improve the quality of life for millions of people.
MISSION
ELE Biotech has emerged with the purpose of addressing an urgent societal need: dementias, which affect more people every day. Our mission focuses on early screening for dementias to improve the quality of life for society. The foundation of ELE Biotech is research and development (R&D), ensuring that our solutions are innovative and effective. We are here to provide hope and a better future for those facing these medical challenges, transforming the way these diseases are managed and treated.
Early Detection
The fundamental pillar of ELE Biotech is the early detection of neurodegenerative diseases through our biomarker.
Life Quality
At ELE Biotech, we firmly believe that early detection of dementias improves the patient’s life expectancy and quality of life.
Enhanced Research
ELE Biotech is a start-up with a strong focus on R&D in biomarkers and diagnostics. Continuous improvement is our only option.
Early Detection
The fundamental pillar of ELE Biotech is the early detection of neurodegenerative diseases through our biomarker.
Life Quality
At ELE Biotech, we firmly believe that early detection of dementias improves the patient’s life expectancy and quality of life.
Enhanced Research
ELE Biotech is a start-up with a strong focus on R&D in biomarkers and diagnostics. Continuous improvement is our only option.
OUR TEAM
The founders have been friends since they were two years old. They cultivated their careers separately: one becoming a scientist in centers of excellence and the other creating and managing businesses. They have decided to join forces to address an unmet need: early screening for dementias. The multidisciplinary team has the perfect combination of experience to bring our device to market through ELE Biotech.
You don’t need to be the best at anything, just the happiest in everything
Laura Vallés Saiz
CSO & Co-Founder